Clovis Oncology, Inc. (CLVS): Price and Financial Metrics

CLVS POWR Grades

• Growth is the dimension where CLVS ranks best; there it ranks ahead of 74.38% of US stocks.
• The strongest trend for CLVS is in Value, which has been heading up over the past 179 days.
• CLVS ranks lowest in Momentum; there it ranks in the 4th percentile.

CLVS Stock Summary

• Clovis Oncology Inc's capital turnover -- a measure of revenue relative to shareholder's equity -- is better than merely 4.65% of US listed stocks.
• CLVS's equity multiplier -- a measure of assets relative to shareholders'equity -- is greater than that of only 3.78% of US stocks.
• The volatility of Clovis Oncology Inc's share price is greater than that of 91.61% US stocks with at least 200 days of trading history.
• If you're looking for stocks that are quantitatively similar to Clovis Oncology Inc, a group of peers worth examining would be ARDX, FBIO, TVTX, SMCI, and INSM.
• Visit CLVS's SEC page to see the company's official filings. To visit the company's web site, go to www.clovisoncology.com.

CLVS Valuation Summary

• CLVS's price/sales ratio is 3.6; this is 68.28% lower than that of the median Healthcare stock.
• Over the past 119 months, CLVS's price/sales ratio has gone NA NA.
• CLVS's EV/EBIT ratio has moved up 1 over the prior 119 months.

Below are key valuation metrics over time for CLVS.

CLVS Growth Metrics

The year over year revenue growth rate now stands at 4.96%.
• The 3 year net cashflow from operations growth rate now stands at -26.15%.
• Its 4 year price growth rate is now at -41.27%.

Over the past 15 months, CLVS's revenue has gone down $11,773,000.

The table below shows CLVS's growth in key financial areas (numbers in millions of US dollars).

Date	Revenue	Operating Cash Flow	Net Income to Common Stock
2021-12-31	148.757	-196.057	-264.524
2021-09-30	156.088	-210.767	-299.093
2021-06-30	156.944	-219.022	-310.359
2021-03-31	160.011	-232.124	-336.158
2020-12-31	164.522	-252.728	-369.212
2020-09-30	160.53	-266.822	-369.756

CLVS's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.

• CLVS has a Quality Grade of C, ranking ahead of 53.47% of graded US stocks.
• CLVS's asset turnover comes in at 0.279 -- ranking 164th of 682 Pharmaceutical Products stocks.
• NEOG, FLXN, and NSTG are the stocks whose asset turnover ratios are most correlated with CLVS.

The table below shows CLVS's key quality metrics over time.